|
🐜
|
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
35 auth.
K. Lynch,
R. Chapman,
S. Keshav,
A. Montaño-Loza,
A. Mason,
A. Kremer,
M. Vetter,
M. de Krijger,
C. Ponsioen,
P. Trivedi,
G. Hirschfield,
C. Schramm,
C. Liu,
C. Bowlus,
Derek J. Estes,
...
D. Pratt,
C. Hedin,
A. Bergquist,
A. D. de Vries,
C. J. van der Woude,
Lei Yu,
D. Assis,
J. Boyer,
H. Ytting,
E. Hallibasic,
M. Trauner,
H. Marschall,
L. Daretti,
M. Marzioni,
Kidist K. Yimam,
N. Perin,
A. Floreani,
B. T. Beretta-Piccoli,
J. Rogers,
C. Levy
|
6 |
2020 |
6
🐜
|
|
🐜
|
Multispectral Optoacoustic Tomography in Crohn's Disease: Noninvasive Imaging of Disease Activity.
15 auth.
M. Waldner,
F. Knieling,
C. Egger,
S. Morscher,
J. Claussen,
M. Vetter,
Christian Kielisch,
S. Fischer,
L. Pfeifer,
A. Hagel,
...
R. Goertz,
D. Wildner,
R. Atreya,
D. Strobel,
M. Neurath
|
6 |
2016 |
6
🐜
|
|
🐜
|
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections
31 auth.
Alan Bénard,
Anne Jacobsen,
M. Brunner,
C. Krautz,
Bettina Klösch,
Izabela J. Swierzy,
E. Naschberger,
M. Podolska,
Dina Kouhestani,
Paul David,
Torsten Birkholz,
Ixchel Castellanos,
D. Trufa,
H. Sîrbu,
M. Vetter,
...
A. Kremer,
K. Hildner,
A. Hecker,
F. Edinger,
M. Tenbusch,
P. Mühl‐Zürbes,
A. Steinkasserer,
E. Richter,
H. Streeck,
M. Berger,
T. Brenner,
M. Weigand,
F. Swirski,
G. Schett,
R. Grützmann,
G. Weber
|
5 |
2020 |
5
🐜
|
|
🐜
|
The Application of Hemospray in Gastrointestinal Bleeding during Emergency Endoscopy
8 auth.
A. Hagel,
H. Albrecht,
A. Nägel,
F. Vitali,
M. Vetter,
Christine Dauth,
...
M. Neurath,
M. Raithel
|
5 |
2017 |
5
🐜
|
|
🐜
|
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19
20 auth.
M. Dugas,
Tanja Grote-Westrick,
U. Merle,
M. Fontenay,
A. Kremer,
F. Hanses,
R. Vollenberg,
E. Lorentzen,
Shilpa Tiwari-Heckler,
J. Duchemin,
...
Syrine Ellouze,
M. Vetter,
Julia Fürst,
P. Schuster,
T. Brix,
C. Denkinger,
C. Müller-Tidow,
H. Schmidt,
Phil Tepasse,
J. Kühn
|
5 |
2020 |
5
🐜
|
|
🐜
|
Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS‐CoV‐2 infection
21 auth.
S. Spoerl,
A. Kremer,
M. Aigner,
Nina Eisenhauer,
Pauline Koch,
Lina Meretuk,
Patrick Löffler,
M. Tenbusch,
C. Maier,
K. Überla,
...
L. Heinzerling,
B. Frey,
G. Lutzny-Geier,
T. Winkler,
G. Krönke,
M. Vetter,
H. Bruns,
M. Neurath,
A. Mackensen,
A. Kremer,
S. Völkl
|
4 |
2021 |
4
🐜
|
|
🐜
|
Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis
9 auth.
A. Györfi,
M. Kopp,
M. May,
M. Vetter,
M. Uder,
A. Kremer,
...
G. Schett,
T. Harrer,
J. Distler
|
4 |
2020 |
4
🐜
|
|
🦁
|
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges
M. Vetter,
M. Neurath
|
4 |
2017 |
4
🦁
|
